Competency profile of locally manufactured clopidogrel lowplat and foreign manufactured clopidogrel plavix in patients of suspected ischemic heart disease (CLAP-IHD)

Journal of the Pakistan Medical Association

Volumn 55, Issue 10, 2005, Pages 443-448

  Ashraf, Tariq ^a   Ahmed, Munir ^a   Talpur, M Saeed ^a   Kundi, Asadullah ^a   Faruqui, Azhar Masood A ^a   Jaffery, Abdul Hafeez ^a   Fareed, Aslam ^b  

^a NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; LOWPLAT;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HYPOTHESIS; ISCHEMIC HEART DISEASE; MALE; PAIN; PAKISTAN; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SWEATING; TABLET; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; VERTIGO; WEAKNESS;

ADMINISTRATION, ORAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUGS, GENERIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PAKISTAN; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; THERAPEUTIC EQUIVALENCY; TICLOPIDINE; TREATMENT OUTCOME; UNITED STATES;

EID: 31344460053     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. George CM, kayser Sr, Adler DS. Thromboembolic disease in; Herfindal ET, Hirshman, jl, Eds. Clinical pharmacy and therapeutics. 6th edition. Baltimore. MD; Williams and Wilkins 1996, pp. 959-72.
2. Diaz Linares M, Rodvold KA, Friedenberg WR. Coagulation disorders. In; Dipiro jt, Talbert RT, Eds Pharmacotherapy, a Pathophysiology Approach 4th ed. Stamford, ct; Appletion and Lange 1999, pp. 1549-72.
3. Easton JD. Evidence with Antiplatelet Therapy and ADP-Receptor Antagonist. Department of Neurology, Brown University, Providence, R.I., USA. Cerebrovasc Dis 2003;16 Suppl 1:20-6.
4. CAPRIE steering committee. A randomized, blinded, trial of clopidogrel versus aspirin at risk of ischemic events (CAPRIE). Lancet 1996;348;1329-39.
5. Antiplatelet Trialist Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
6. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with Ischemic heart diseases without ST-segment elevation. N Engl J Med 2001;345:494-502.
7. [Erratum, N Engl J Med 2001;345:1506.
8. Born GVR. Quantitative investigations into the aggregation of blood platelets. J. Physiol Lond 1962;162:67-
9. Clopidogrel product monograph, May 2003.
10. Iris M, Melchior S, Silja R. Effect of High Loading Dose of Clopidogrel on Platelet Functions in Patient's Undergoing Coronary Stent Placement. Heart 2001;85:92-3.
11. Iris M, Felicitas B, Christian S. Prevalence of Clopidogrel Non-Responders Among Patients With Stable Angina Pectoris Schedule for Elective Coronary Stent Placement. Thromb Haemost 2003;89:78-7.
12. Yan BP, Clark DJ, Ajani AE. Oral antiplatelet therapy and percutaneous coronary intervention. Expert Opin Pharmacother 2005;6:3-12.
13. Harber LA, Bruno JB: Ticlopidine Mechanism of Action On Human Platelets. Has WK, Easter JD (Eds): Ticlopidine, Platelets and Vascular Disease, New York, Springer-Verlag 1993, pp. 41-59.
14. Sweeny JD, Hoernig LA, Michnik BS, Fitzpatrick JE. Whole blood platelet aggregation predicts in vitro and in vivo haemostatic function in the elderly. Arterioscler Thromb Vasc Biol 1995;15:748-53.
15. Ingerman-Wojenski CM, Silver MJ. Quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer. Thromb Haemost. 1984;51:154-6.
16. Cardinal DC, Flower RJ. The electronic aggregometer: A novel device of assessing platelet behavior in blood. J Pharmacol Meth 1980;3:1350-8.
17. Riess H, Braun G, Hiller E. Critical evaluation of platelet aggregation in whole blood. Am J Clin Pathol 1986;85:50-6.
18. Sweeny JD, Hoernig LA, Michnik BS, Fitzpatrick JE. Whole blood aggregometry: influence of sample collection and delay in study performance on test results. J Clin Pathol 1989;92:676-9.
19. Chronolog user manual, 2004.
20. CERI, Health care product comparison system 1999;8:16.
21. Mary A, Seth W, Nicholas J. V. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy. Circulation 1997;96:3860-6.
22. Bertrand ME, Rupprecht H-J, Urban P. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-9.
23. Yusuf S, Zhao F, Mehta SR. For the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
24. Mehta SR, Yusuf S, Peters RJG. For the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
25. Steven R. Steinhubl, Peter B. For the CREDO Investigators Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Randomized Controlled Trial JAMA 2002;288:2411-20.
26. COMMIT/CCS-2 (ClOpidogrel and Metoprolol in Myocardial Infarction Trial), ACC's 54 Annual Scientific Sessions in Orlando, Florida, 9 March 2005.
27. Marc SS, Christopher PC, Michael GC. CLARITY - TTMI 28 (CLopidogrel as Adjunctive ReperfusIon TherapY - Thrombolysis In Myocardial Infarction Study 28). N Engl J Med 2005;352:12.